Observations from the OMERACT Drug Safety Summit, May 2008

Simon, L. S., Strand, C. V., Boers, M., Brooks, P. M., Henry, D. and Tugwell, P. S. (2009) Observations from the OMERACT Drug Safety Summit, May 2008. The Journal of Rheumatology, 36 9: 2110-2113. doi:10.3899/jrheum.090590

Author Simon, L. S.
Strand, C. V.
Boers, M.
Brooks, P. M.
Henry, D.
Tugwell, P. S.
Title Observations from the OMERACT Drug Safety Summit, May 2008
Journal name The Journal of Rheumatology   Check publisher's open access policy
ISSN 0315-162X
Publication date 2009-09
Year available 2009
Sub-type Article (original research)
DOI 10.3899/jrheum.090590
Volume 36
Issue 9
Start page 2110
End page 2113
Total pages 4
Editor Dr Duncan A Gordon
Yvonne Pigott
Place of publication Canada
Publisher Journal of Rheumatology Publishing Co Ltd
Collection year 2010
Language eng
Subject C1
111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
929999 Health not elsewhere classified
Abstract Due to mounting concern about determination of benefit and risk in the context of product development and clinical practice the OMERACT Executive identified the need to bring together a variety of specialists to define risk. At the Drug Safety Summit held at OMERACT 9, specialists spoke on their given topics and the group considered risk in the context of formally posed questions.
Keyword clinical trials
drug safety
Risk assessment
Q-Index Code C1
Q-Index Status Confirmed Code

Document type: Journal Article
Sub-type: Article (original research)
Collections: Faculty of Health and Behavioural Sciences -- Publications
2010 Higher Education Research Data Collection
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 4 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Thu, 22 Apr 2010, 13:30:29 EST by Sharon Doyle on behalf of Faculty Of Health Sciences